A Miracle Treatment! Or Not?

By Daniel J. Merenstein, MD, Professor, Department of Family…

The past decade of probiotics and prebiotics research: ISAPP board members share their perspectives.

By ISAPP board members, compiled by Kristina Campbell Scientific…

The FDA’s view on the term probiotics, part 1

By James Heimbach, Ph.D., F.A.C.N., JHEIMBACH LLC, Port Royal,…

Probiotics, Prebiotics and Globobiotics!

By Prof. Colin Hill, PhD, APC Microbiome Ireland, University…

Maintaining a family tradition: Bulgarian whole fermented cabbage

By Mariya Petrova, PhD, Microbiome insights and Probiotics Consultancy,…

Highlighting the importance of lactic acid bacteria: An interview with Prof. Seppo Salminen

By Kristina Campbell, M.Sc., science & medical writer   In…

Misleading press about probiotics: ISAPP responses

By Mary Ellen Sanders, PhD, Executive Science Officer, ISAPP It…

Lactobacillus bacteremia in critically ill patients does not raise questions about safety for general consumers

By Dan Merenstein MD, Professor of Family Medicine, Georgetown…

Reflections on a career in probiotic science, from ISAPP founding board member Prof. Gregor Reid

Past President and founding board member Prof. Gregor Reid is…

Those probiotics may actually be helping, not hurting

By Mary Ellen Sanders PhD, Executive Science Officer, ISAPP,…

Researchers submit recommendations for revised Lactobacillus taxonomy

By Mary Ellen Sanders PhD, Executive Science Officer, ISAPP A…